Vitamin Shoppe now CL-Buy at Goldman


Vitamin Shoppe (VSI) lands on the coveted Conviction Buy list at Goldman.

Analyst Stephen Tanal expects "sharp acceleration in same-store sales growth in Q4 [and says] artificially depressed 2013 EBIT margins are set to inflect."

Price target hiked to $65 from $59.

In Q3, comps printed at +2.6%, marking the 32nd consecutive quarter of positive SSS growth.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs